Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04398719
EARLY_PHASE1

CBD-Microglia PET Study

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This study aims to examine the effect of cannabidiol (CBD) pre-treatment on brain microglial activation in healthy human subjects. Secondarily, this study aims to examine the effect of cannabidiol (CBD) pre-treatment on central pain-sensitization in healthy human subjects.

Official title: Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2021-05-07

Completion Date

2025-09-30

Last Updated

2025-07-18

Healthy Volunteers

Yes

Conditions

Interventions

RADIATION

[11C]PBR28

The radiotracer, \[11C\]PBR28, will be administered at the beginning of each PET scan

DRUG

Low-dose lipopolysaccharide

Subjects will receive intravenous lipopolysaccharide.

DRUG

Intradermal Capsaicin

A small dose of capsaicin will be administered by intradermal injection.

Locations (1)

Connecticut Mental Health Center

New Haven, Connecticut, United States